Sandbox: nima
Overview
The majority of patients with Hepatic encephalopathy are asymptomatic.[1]
OR
The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
History and Symptoms
Hepatic encephalopathy or portosystemic encephalopathy is a syndrome of largely reversible impairment of brain function occurring in patients with acute or chronic liver failure or when the liver is bypassed by portosystemic shunts.[2]
- The hallmark of Hepatic Encephalopathy is . A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
- Symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
History
Patients with [disease name]] may have a positive history of:
- [History finding 1]*Viral Hepatitis
- Chronic alcohol use
- [History finding 2]
- [History finding 3]
Common Symptoms
Common symptoms of hepatic encephalopathy include:[3]
- Jaundice
- Altered mental status
- Hepatomegaly
- memory impairment
How To
About NCBI Accesskeys
Z Gastroenterol. 2005 Apr;43(4):373-8.
[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
[Article in German]
Hass HG1, Nägele T, Seeger U, Hösl F, Gregor M, Kaiser S.
Author information
Hepatic encephalopathy (HE) is a common problem in liver cirrhosis and is associated with typical changes of cerebral metabolite pattern observed by proton magnetic resonance spectroscopy (MRS).
LinkOut - more resources
•
Supplemental Content
Full text links
Icon for Georg Thieme Verlag Stuttgart, New York
Save items
Add to Favorites
View more options
Similar articles
Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
[Am J Gastroenterol. 1999]
Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. [Hepatology. 1997]
Clinical correlation of neuropsychological tests with 1H magnetic resonance spectroscopy in hepatic encephalopathy. [Psychosom Med. 1998]
Review Cerebral changes in hepatic encephalopathy. [J Gastroenterol Hepatol. 1998]
Review A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment. [Arq Gastroenterol. 2009]
See reviews...
See all...
Related information
MedGen
PubChem Compound
PubChem Compound (MeSH Keyword)
PubChem Substance
Recent Activity
You are here: NCBI > Literature > PubMed Support Center
Simple NCBI Directory
Getting Started
NCBI Education
NCBI Help Manual NCBI Handbook Training & Tutorials Submit Data
Resources
Chemicals & Bioassays
Data & Software DNA & RNA Domains & Structures Genes & Expression Genetics & Medicine Genomes & Maps Homology Literature Proteins Sequence Analysis Taxonomy Variation
Popular
PubMed Bookshelf PubMed Central BLAST Nucleotide Genome SNP Gene Protein PubChem
Featured
Genetic Testing Registry GenBank Reference Sequences Gene Expression Omnibus Genome Data Viewer Human Genome Mouse Genome Influenza Virus Primer-BLAST Sequence Read Archive
NCBI Information
About NCBI Research at NCBI NCBI News & Blog NCBI FTP Site NCBI on Facebook NCBI on Twitter NCBI on YouTube Privacy Policy
NLM NIH DHHS USA.gov
National Center forBiotechnology Information, U.S. National Library of Medicine
8600 Rockville Pike, Bethesda MD, 20894 USA
Policies and Guidelines | Contact
Less Common Symptoms
Less common symptoms of [disease name] include
- [Symptom 2]
- [Symptom 3]
References
- ↑ Jeong JH, Kim DK, Lee NS, Jeong YG, Kim HW, Kim JS, Han SY (2018). "Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction". ASN Neuro. 10: 1759091418810583. doi:10.1177/1759091418810583. PMID 30428281.
- ↑ Schulz C, Schütte K, Vilchez-Vargas R, Vasapolli R, Malfertheiner P (November 2018). "Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy". Dig Dis: 1–9. doi:10.1159/000494216. PMID 30428474.
- ↑ . PMID 30427626. Missing or empty
|title=(help)